Cipla USA Recalls Cinacalcet Hydrochloride Tablets Over Nitrosamine Hazard
Cipla USA, Inc. recalled 15,744 bottles of Cinacalcet Hydrochloride Tablets on November 14, 2025. The recall follows the discovery of a nitrosamine impurity exceeding acceptable daily intake limits. Consumers should stop using the product immediately and consult healthcare providers.
Quick Facts at a Glance
Recall Date
November 14, 2025
Hazard Level
HIGH
Brands
CINACALCET, Cipla USA Inc.
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL
Hazard Information
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
What You Should Do
Consumers and healthcare providers should stop using this product immediately. Contact Cipla USA, Inc. or your healthcare provider for guidance. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
No spamUnsubscribe anytime
About This Product
Cinacalcet Hydrochloride Tablets are prescribed for managing conditions related to parathyroid hormone levels, particularly in patients with chronic kidney disease. They help regulate calcium levels in the body, making them essential for certain patients.
Why This Is Dangerous
The presence of N-nitroso-cinacalcet in the tablets poses a health risk as it exceeds acceptable daily intake limits. This impurity can lead to serious health consequences if consumed regularly.
Industry Context
This recall is not part of a broader industry pattern.
Real-World Impact
Consumers may face health risks associated with the impurity in the recalled tablets. The urgency to stop use and seek alternatives may lead to disruptions in treatment for some patients.
Practical Guidance
How to identify if yours is affected
Locate the lot number on your bottle of Cinacalcet Hydrochloride Tablets.
Check if it matches Lot 5PB0164.
Confirm the expiration date is January 31, 2027.
Where to find product info
The lot number and expiration date can typically be found on the label or bottom of the bottle.
What timeline to expect
Expect a refund or further instructions within 4-6 weeks following the recall notification.
If the manufacturer is unresponsive
Contact Cipla USA, Inc. directly via phone or email.
Document all correspondence regarding the recall.
How to prevent similar issues
Always check for recent recalls on medications before use.
Consult your healthcare provider about alternatives if a recall occurs.
Documentation advice
Keep receipts, correspondence with the manufacturer, and any medical records related to your use of the affected product.
Product Details
The recall involves Cinacalcet Hydrochloride Tablets, 60 mg, sold in 30-tablet bottles. The affected lot is Lot 5PB0164, which has an expiration date of January 31, 2027. The product was distributed nationwide in the United States.
Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.
Mazda North American Operations recalls 2025 Mazda CX-70 plug-in hybrids as software issues in the inverter may cause the malfunction indicator lights to illuminate and a loss of drive power in EV mode. Dealers will update inverter software at no cost. Letters were mailed December 19, 2024.
Mazda North American Operations recalls certain 2024-2025 CX-90 and 2025 CX-70 vehicles with a Dash ESU due to startup function failures. Software reprogramming will remedy the issue at no charge. Owner notices were mailed December 18, 2024. Contact Mazda at 1-800-222-5500 Option 6. NHTSA ID 24V814000.
Subaru recalls 2025 Forester vehicles due to potentially loose child seat anchor bolts. Dealers will inspect and tighten bolts at no charge. Owner letters are expected August 15, 2025. Contact Subaru at 1-844-373-6614. Recall number WRC-25.
Nissan recalls 2025 Pathfinder, Murano and INFINITI QX60 for front brake caliper weakness that could fail. Dealers will inspect and replace calipers as needed, free of charge. Letters sent May 9, 2025. Contact Nissan or INFINITI for remedies.
Mazda North American Operations is recalling 2025 CX-50 Hybrid and CX-50 SUVs sold through Mazda dealers. Incorrectly configured restraint-control software may cause the air bag to deploy improperly. Owner notification letters are expected to be mailed August 17, 2025.
Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.
BMW recalls 2025-2026 X1 and X2 models plus MINI Cooper and Countryman variants for front seat belt retractors with damaged torsion bars. The defect may fail to restrain occupants in a crash. Dealers will replace both front retractors at no cost. Owner letters begin November 7, 2025. VIN lookup will be available on NHTSA.gov the same day.